Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway - Test2 - elhamkhani - TriplyDB

Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway

Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway

http://www.wikidata.org/entity/Q28216760

about

sameAs

Interventions for actinic keratoses Immunostimulants for preventing respiratory tract infection in children Immunostimulants for preventing respiratory tract infection in children SIGIRR inhibits interleukin-1 receptor- and toll-like receptor 4-mediated signaling through different mechanisms Gene expression and antiviral activity of alpha/beta interferons and interleukin-29 in virus-infected human myeloid dendritic cells Toll-like receptor 3-mediated activation of NF-kappaB and IRF3 diverges at Toll-IL-1 receptor domain-containing adapter inducing IFN-beta Essential role for the prolyl isomerase Pin1 in Toll-like receptor signaling and type I interferon-mediated immunity Measles virus V protein is a decoy substrate for IkappaB kinase alpha and prevents Toll-like receptor 7/9-mediated interferon induction Innate immune recognition of viral infection Plasmacytoid dendritic cells: linking innate and adaptive immunity Recognition of single-stranded RNA viruses by Toll-like receptor 7 Nonsurgical innovations in the treatment of nonmelanoma skin cancer Pathogen recognition and inflammatory signaling in innate immune defenses Microbe sensing, positive feedback loops, and the pathogenesis of inflammatory diseases Effect of resiquimod 0.01% gel on lesion healing and viral shedding when applied to genital herpes lesions CD200 receptor controls sex-specific TLR7 responses to viral infection Toll-like receptors: a family of pattern-recognition receptors in mammals.Toll-like receptor downstream signaling.Systemic lupus erythematosus and the type I interferon system Molecular mechanisms of autoimmunity triggered by microbial infection.Toll-Like Receptor 7-Targeted Therapy in Respiratory Disease Holding the Inflammatory System in Check: TLRs and Their Targeted Therapy in Asthma Liposome-Based Adjuvants for Subunit Vaccines: Formulation Strategies for Subunit Antigens and Immunostimulators CpG Oligonucleotides as Cancer Vaccine Adjuvants Pattern Recognition Receptors in Cancer Progression and Metastasis Sensors of Infection: Viral Nucleic Acid PRRs in Fish Systems biology applied to vaccine and immunotherapy development The Yin and Yang of Toll-like receptors in cancer Interferon induction by RNA viruses and antagonism by viral pathogens Toll-like receptors: key players in antiviral immunity Interplay between Inflammation and Cellular Stress Triggered by Flaviviridae Viruses RNA mediated Toll-like receptor stimulation in health and disease Calcitonin gene-related peptide: key regulator of cutaneous immunity Understanding dendritic cells and their role in cutaneous carcinoma and cancer immunotherapy Toll-like receptors in antiviral innate immunity Recent insights into the evolution of innate viral sensing in animals Development of a cell system for siRNA screening of pathogen responses in human and mouse macrophages Tumor Progression Locus 2 Promotes Induction of IFNλ, Interferon Stimulated Genes and Antigen-Specific CD8+ T Cell Responses and Protects against Influenza Virus Translational mini-review series on Toll-like receptors: recent advances in understanding the role of Toll-like receptors in anti-viral immunity Investigating Toll-Like Receptor Agonists for Potential To Treat Hepatitis C Virus Infection

P2860

Q24202407-B9F6A277-CEFD-4E72-8608-4347571E8872 Q24243914-D73FE5C8-E55C-4A85-9FD3-A07D678E10F0 Q24246390-B7B1A749-D761-4A52-B301-7BDCE38FB639 Q24301289-F63477C4-624D-4C2A-BEA2-C0FD1C0DEF93 Q24307725-51880016-BB81-4D7E-8F37-A635E4EBD29C Q24311833-16445AB1-BF03-4D56-A47D-922366A2A829 Q24312889-AD3DDCD2-F4D5-4E08-93AF-600D7106D0A4 Q24323244-4352D4E9-6EDB-4CE8-94FD-F6BE23C13E82 Q24498364-0C747376-DF03-4276-9A44-7A6771D8CEE7 Q24558695-787A4894-9D8B-44EB-A4E0-F67B238620DA Q24568101-2C39868C-6B88-4CCC-BDE2-9C1ABE181116 Q24632006-19301BE8-206C-4649-AF36-E2C37F5DB909 Q24643034-A55BA806-FE3C-4251-8E0E-80EF0FCC7CF2 Q24647287-7020508A-BBCF-47DC-9255-9B65988ADB65 Q24656625-C8A26FC5-69E3-4302-B1A6-A1380D5A51E8 Q24706510-DC90C98C-D9E5-4C58-B613-05995A847024 Q24792671-81327A5A-7813-4F3B-89CB-49D20F85B5BF Q24799256-77AFED77-6ECB-45E9-A601-653736BC6387 Q24804235-68E1531C-7138-41FC-8423-D6261F27B4FF Q24812576-1DB206B4-63BA-403F-8DA1-3E684F271713 Q26745901-A8E05B4D-1D2D-4F58-88BA-7164DDDA9C50 Q26747627-A81379A8-9361-46B4-87EB-1449FAA8CD0A Q26765446-A14D4DEA-4F1E-42E4-9AB2-79EA589688C8 Q26783826-1E560D55-EED5-4049-8696-ADC375C151F5 Q26798034-AF5E6609-329D-4F75-8642-96C0D6F35667 Q26799867-E0A93488-9FD5-449C-817E-70560A23997E Q26830374-33C41F42-E179-4444-9846-6D34F36942DA Q26851526-368EDA05-482F-42E1-9FCB-6819A06EF967 Q26860007-04813BE7-A3FE-4198-A9E5-920D40DAA969 Q26865983-8216189D-4D79-4A21-9E70-35AB0EB44A9A Q26970803-E1F7F4B3-3864-40AD-9D13-968277BB1A39 Q26999252-9079059F-B291-450B-BDD4-575C5D3EA126 Q26999447-82121436-2FCD-40DC-AC80-874729400DC4 Q27004702-42C1FD00-0951-4B5C-A796-947F465D6B42 Q27011462-FF4A0754-4610-49BC-BFBC-BC8DD123250D Q27026305-DE3694D4-1E95-4503-A8FD-555DC5555849 Q27309056-4E78EB26-E54E-48C7-8BCF-DD4A1ACCFC44 Q27318631-17CDFA48-3C16-4B18-8EDB-947579B7F656 Q27478142-2AFED734-9048-4AAB-B231-E38F22AD278F Q27480922-F6FA0E85-F817-47B1-908F-B8E5B2D40BD2

P2860

Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway

http://www.wikidata.org/entity/Q28216760

description

2002 nî lūn-bûn

@nan

2002 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Small anti-viral compounds act ...... 88-dependent signaling pathway

@ast

Small anti-viral compounds act ...... 88-dependent signaling pathway

@en

Small anti-viral compounds act ...... 88-dependent signaling pathway

@nl

type

label

Small anti-viral compounds act ...... 88-dependent signaling pathway

@ast

Small anti-viral compounds act ...... 88-dependent signaling pathway

@en

Small anti-viral compounds act ...... 88-dependent signaling pathway

@nl

prefLabel

Small anti-viral compounds act ...... 88-dependent signaling pathway

@ast

Small anti-viral compounds act ...... 88-dependent signaling pathway

@en

Small anti-viral compounds act ...... 88-dependent signaling pathway

@nl

P1433

Q28216760-6F54B44F-A1A7-490F-89BB-ECECAA42BE78

P1476

Q28216760-278B33F9-BFBE-45D8-87B6-7BC3B33F74FB

P2093

Q28216760-121015A8-8301-4BEE-99EF-B9D58926B330

Q28216760-23A9EA15-401E-433E-9D25-5E6D05A56BE7

Q28216760-33596137-0E2E-45D7-958D-6DC5EAC5CAF7

Q28216760-3E975034-8914-44C7-BFB4-3A8FB22FBCE6

Q28216760-7CD3B6FE-B211-4FB3-A962-F5266803E8BB

Q28216760-8A09749C-59A6-4D62-AE16-47990205B073

Q28216760-B2B742BC-BFE4-4417-8583-31939F05CF40

Q28216760-B8439922-C128-4D87-A13E-AC33B04E5986

Q28216760-FE716484-F203-436B-BDFB-1C5D3D22F826

P304

Q28216760-50094DA5-A7FC-45FA-BFC7-5BEC171B4056

P31

Q28216760-90ED56D2-8714-49E7-864C-3034C7C92ECD

P3181

Q28216760-866D6158-3419-43F2-A943-C58AFB3785B9

P356

Q28216760-342383DF-C9C3-49BA-953E-72E0BC2652E6

P407

Q28216760-DA103A62-4C13-4FD2-B8F6-36949D535C72

P433

Q28216760-5D78EC11-43A8-4121-BFC0-D153561E0642

P478

Q28216760-607AC270-6830-4C27-B8FA-CCE3A2255F7C

P50

Q28216760-62F67516-C336-4D18-AA47-1579F79C7B51

P577

Q28216760-B64689D5-99DF-40C7-93D8-1711A39F5396

P5875

Q28216760-8F12913F-B75C-4DD0-A2D5-184B8323CFFD

P698

Q28216760-6465B8DD-7C52-425B-B939-36A762300E8A

P921

Q28216760-F5E4FDCF-F192-4A70-B2F8-C895CBE2C5EA

P3181

P356

P1433

Nature Immunology

P1476

Small anti-viral compounds act ...... 88-dependent signaling pathway

@en

P2093

Hideki Sanjo

http://www.w3.org/2001/XMLSchema#string

Hideyuki Tomizawa

http://www.w3.org/2001/XMLSchema#string

Hiroaki Hemmi

http://www.w3.org/2001/XMLSchema#string

Katsuaki Hoshino

http://www.w3.org/2001/XMLSchema#string

Kiyoshi Takeda

http://www.w3.org/2001/XMLSchema#string

Osamu Takeuchi

http://www.w3.org/2001/XMLSchema#string

Shintaro Sato

http://www.w3.org/2001/XMLSchema#string

Takao Horiuchi

http://www.w3.org/2001/XMLSchema#string

Tsuneyasu Kaisho

http://www.w3.org/2001/XMLSchema#string

P304

196-200

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1285769

http://www.w3.org/2001/XMLSchema#string

P356

10.1038/NI758

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P50

P577

2002-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11546498

http://www.w3.org/2001/XMLSchema#string

P698

11812998

http://www.w3.org/2001/XMLSchema#string

P921

Toll-like receptor